• 中文核心期刊要目总览
  • 中国科技核心期刊
  • 中国科学引文数据库(CSCD)
  • 中国科技论文与引文数据库(CSTPCD)
  • 中国学术期刊文摘数据库(CSAD)
  • 中国学术期刊(网络版)(CNKI)
  • 中文科技期刊数据库
  • 万方数据知识服务平台
  • 中国超星期刊域出版平台
  • 国家科技学术期刊开放平台
  • 荷兰文摘与引文数据库(SCOPUS)
  • 日本科学技术振兴机构数据库(JST)
Han-Qiong LUO, NJie SHE, Cai-Ping CHEN, Xiao MA, Chao LIN, Qiong OUYANG, Chun-Xiao XUAN, Jine LIU, Hong-Bin SUN, Jun LIU. Lipid-lowering effects of oleanolic acid in hyperlipidemic patients[J]. Chinese Journal of Natural Medicines, 2018, 16(5): 339-346. DOI: 10.1016/S1875-5364(18)30065-7
Citation: Han-Qiong LUO, NJie SHE, Cai-Ping CHEN, Xiao MA, Chao LIN, Qiong OUYANG, Chun-Xiao XUAN, Jine LIU, Hong-Bin SUN, Jun LIU. Lipid-lowering effects of oleanolic acid in hyperlipidemic patients[J]. Chinese Journal of Natural Medicines, 2018, 16(5): 339-346. DOI: 10.1016/S1875-5364(18)30065-7

Lipid-lowering effects of oleanolic acid in hyperlipidemic patients

  • Abstract: Oleanolic acid (OA) is a pentacyclic triterpenoid compound extracted from olea europaeal, a traditional Chinese medicine herb. OA has been used in the clinic as a hepatoprotective medicine in China since 1970s. In our previous study, we observed that OA could ameliorate hyperlipidemia in animal models. In the present study, we conducted a small-scale clinical trial to evaluate the hypolipidemia effect of OA in hyperlipidemic patients. Hyperlipidemic patients were administrated with OA for four weeks (4 tablets once, three times a day). The blood samples of the patients were collected before and after OA treatment. The biological parameters were measured. Furthermore, three patients' blood samples were studied with DNA microarray. After OA administration, the TC, TG, and HDLC levels in serum decreased significantly. DNA microarray analysis results showed that the expressions of 21 mRNAs were significantly changed after OA treatment. Bioinformatics analysis showed 17 mRNAs were up-regulated and 4 mRNAs were down-regulated significantly after OA treatment. Five mRNAs (CACNA1B, FCN, STEAP3, AMPH, and NR6A1) were selected to validate the expression levels by qRT-PCR. Therefore, OA administration differentially regulated the expression of genes involved in lipid metabolism. The data showed a clinical evidence that OA could improve hyperlipidemia and also unveiled a new insight into the molecular mechanisms underlying the pharmacological effect of OA on hyperlipidemia.

     

/

返回文章
返回